We’re excited to share Global Clinical Trial’s (GCT) success enrolling stroke patients in Georgia—reaching its targeted enrollment in just 6 months, half the time originally projected.
This milestone reflects not only the dedication and efficiency of our Georgian clinical team and partner sites, but also the strong collaboration between the Sponsor and Investigators.
Dr. Eugene Selivra, GCT CEO, said, “Achieving recruitment goals is a key success factor in clinical research, as it significantly accelerates timelines and reduces costs for the sponsor. We extend our gratitude to everyone involved—this success is not just about numbers but about bringing new hope and therapies closer to patients in need worldwide.”